In the last trading session, 0.11 million shares of the Bluebird bio Inc (NASDAQ:BLUE) were traded, and its beta was 0.70. Most recently the company’s share price was $8.35, and it changed around $0.09 or 1.09% from the last close, which brings the market valuation of the company to $81.18M. BLUE currently trades at a discount to its 52-week high of $38.40, offering almost -359.88% off that amount. The share price’s 52-week low was $5.80, which indicates that the current value has risen by an impressive 30.54% since then. We note from Bluebird bio Inc’s average daily trading volume that its 10-day average is 0.2 million shares, with the 3-month average coming to 406.86K.
Bluebird bio Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.20. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 6 recommended BLUE as a Hold, whereas 1 deemed it a Buy, and 2 rated it as Underweight.
Bluebird bio Inc (NASDAQ:BLUE) trade information
Instantly BLUE has showed a green trend with a performance of 1.09% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.75 on recent trading dayincreased the stock’s daily price by 4.57%. The company’s shares are currently up 0.12% year-to-date, but still down -1.30% over the last five days. On the other hand, Bluebird bio Inc (NASDAQ:BLUE) is 6.91% up in the 30-day period. We can see from the shorts that 47.71 million shares have been sold at a short interest cover period of 9.53 day(s).
The consensus price target as assigned by Wall Street analysts is $12.5, which translates to bulls needing to increase their stock price by 33.2% from its current value. Analyst projections state that BLUE is forecast to be at a low of $5 and a high of $25.
Bluebird bio Inc (BLUE) estimates and forecasts
Bluebird bio Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -63.70 percent over the past six months and at a 29.61% annual growth rate that is well above the industry average of 16.50%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 28.98%.
BLUE Dividends
Bluebird bio Inc’s next quarterly earnings report is expected to be released in February.
Bluebird bio Inc (NASDAQ:BLUE)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.63% of Bluebird bio Inc shares, and 43.69% of them are in the hands of institutional investors. The stock currently has a share float of 43.96%. Bluebird bio Inc stock is held by 196.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 14.1544% of the shares, which is about 15.44 million shares worth $15.2 million.
VANGUARD GROUP INC, with 9.4422% or 10.3 million shares worth $10.14 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
